Request Information
Request Information
We are excited to announce the MONARCH® Platform now features two indications, one for bronchoscopy and one for urology.
With the MONARCH® Platform, Auris, now owned by Ethicon, seeks to leverage the power of flexible robotics to enable new possibilities in endoscopy, which uses small cameras and tools to enter the body through its natural and percutaneous channels.
By integrating the latest advancements in robotics, micro instrumentation, endoscope design, sensing, and data science, MONARCH® is designed with the goals of improving patient outcomes and reducing hospital costs in both bronchoscopy and kidney procedures.
We started by focusing on lung cancer and will now help physicians tackle kidney stones. The MONARCH® Platform is intended for diagnostic and therapeutic bronchoscopic and urologic procedures. Read indications for use.
Ethicon, Inc. is a Johnson & Johnson MedTech Company.
Bronchoscopy Important Safety Statement:
Complications from bronchoscopy are rare and most often minor, but if they occur, may include breathing difficulty, vocal cord spasm, hoarseness, slight fever, vomiting, dizziness, bronchial spasm, infection, low blood oxygen, bleeding from biopsied site, or an allergic reaction to medications. Only rarely do patients experience other more serious complications (for example, collapsed lung, respiratory failure, heart attack and/or cardiac arrhythmia).
Urology Important Safety Statement:
Adverse effects from both Mini-PCNL and Ureteroscopy include pain, urinary tract infection, fever, hematuria (presence of blood in urine), exposure to low levels of radiation, retained or residual stones.
Adverse effects from ureteroscopy may include pain, perforation or injury to the ureter, resulting in extravasation of fluid and urine (urinoma), stricture of the ureter with risk of subsequent obstruction (hydronephrosis needing further repair), rare avulsion of the ureter, urinary blood clots, residual stones.
PCNL access may result in minor and major adverse effects. Minor effects include fever and nephrostomy leak. Major adverse effects may include injuries to pleura, liver, spleen, large vessels with related bleeding, gallbladder, duodenum, jejunum, colon with related cutaneous fistula, fever, pain, ileus, elevated counts.
Major adverse effects related to stone removal may include infection and urosepsis, intravascular fluid overload, extravasation of fluid, and post percutaneous nephrolithotomy bleeding.